Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vibroacoustic Therapy for Nasal Congestion in Allergic Rhinitis
NCT07114107Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial (4 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Peak Nasal Inspiratory Flow at 8 weeks. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07114107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07114107.